Impression Healthcare (ASX:IHL)
- CEO:Joel Latham
Impression Healthcare (ASX:IHL) Company Overview
Impression Healthcare (ASX:IHL) started life as a manufacturer and supplier of custom-fit mouthguards, and other dental equipment. The Oral devices business continues to show strong revenue growth from all products; including, sports mouthguards for teeth protection and to reduce concussion risk, and sophisticated devices made to combat sleep apnoea, snoring and bruxism.
The other side of the company is a rapidly expanding Medicinal cannabis business with four unique clinical trials in partnership with Swinburne University of Technology, that are complementary to the issues they currently aim to prevent with the range of oral devices.
IHL's cannabinoid drug discovery brand Incannex Pharmaceuticals is a collaboration with an EU-based cannabinoid drug design company named Linnea SA. The EU-based company will serve as IHL's supply partner for the base cannabinoid materials in four novel cannabinoid formulations.
IHL has also secured Australian licenses in place to import, export and distribute cannabis products and access to Cannvalate – the largest network of cannabis medicine prescribers in Australia.
Stay updated about
Signup to get updates.